TrialProceedings of the National Academy of Sciences of the United States of America2008

Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in mice.

Qi Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.